• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Roche`s Lunsumio Approved in Canada

    HEALTH CANADA

    Roche’s Piasky Recieves Approved in Canada

    HEALTH CANADA

    Roche`s Piasky (Crovalimab) Receives Approval in Europe

    EMA

    Roche` Lunsumio (mosunetuzumab) Receives Approval in Europe

    EMA

    Roche`s Vabysmo (faricimab) Receives Approval in Europe

    EMA

    Roche`s Columvi (glofitamab) Receives Approval in Europe

    EMA

    Roche`s Gavreto (pralsetinib) Receives Approval in Europe

    EMA

    Roche`s Ronapreve (casirivimab, imdevimab) Approved in Europe

    EMA

    Roche`s Biologic Yircera ( Methoxypolyethylene Glycol) Receives Approval in the U.S.)

    FDA

    Roche`s Biologic Mircera (Methoxypolyethylene Glycol) Receives Approval in the U.S.

    FDA

    Roche Registration Lunsumio (mosunetuzumab) Receives Approval in Europe

    EMA

    Roche`s Biologic Gavreto (Pralsetinib) Receives Approval in Europe

    EMA

    Roche`s Biologic Ronapreve (Casirivimab/Imdevimab) Receives Approval in Europe

    EMA

    Roche`s Ronapreve (casirivimab, imdevimab) Receives Approval in Europe

    EMA

    Roche`s Enspryng (satralizumab) Receives Approval In Europe

    EMA

    Hoffmann-La Roche`s Pegasys (peginterferon) Receives Supplemental Approval in US

    FDA

    Roche Registration GmbH Polivy (polatuzumab vedotin)Receives Approval in Europe

    EMA

    Genentech’s Tecentriq (Atezolizumab) Receives Supplemental Approval In The US

    FDA

    Roche`s RoActemra(tocilizumab) Receives Approval in Europe

    EMA

    Hoffman La Roche`s Mircera (methoxy polyethylene glycol / epoetin beta) Receives Supplemental Approval In US

    FDA

    Roche Registration Limited Ocrevus (ocrelizumab) Receives Approval In Europe

    EMA

    Roche`s Tecentriq (atezolizumab) Receives Approval In Europe

    EMA

    Roche Registration Limited Alecensa (alectinib) Recommend Its Authorisation in The Europe

    EMA

    Hoffman La Roche`s Alecensa (Alectinib) approved in US for advanced ALK-rearranged non-small cell lung cancer

    FDA

    Roche`s Avastin Plus (Bevacizumab) Approved in Europe For Cervical Cancer

    ROCHE

    Regeneron`s Eylea (Aflibercept) Approved in U.S. for Diabetic Retinopathy

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.